AKESF
AKESO INCstockOTC
EODNov 13, 2026
10.30USD-3.379%(-0.36)1,510
AKESF News
Akeso's Gumokimab (IL-17A) Receives NMPA Approval for Active Ankylosing Spondylitis ·
PR Newswire+1 source
Ivonescimab Receives NMPA Priority Review for First-Line Biliary Tract Cancer ·
PR Newswire+1 source